This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Retail Genomics Market

Retail Genomics Market

Retail Genomics Market Forecast, Trend Analysis & Competition Tracking - Global Review 2021 to 2031

Retail Genomics Market
FACT6316MR

Retail Genomics Market Forecast and CAGR

According to the latest research by Fact.MR., the Retail Genomics market is set to witness significant growth during 2021-2031. Retail Genomics the branch in which sequencing, investigation, and analysis of the genome of an individual are included.

What is Driving Demand for Retail Genomics?

The increase in nucleic acid sequencing and requirement for preventive care will give rise to the Retail Genomics market. Retail Genomics tests usually have no involvement of a medical practitioner. They are used for knowing the family history of related medical symptoms. This information would help the consumer to make better decisions and take preventive care.

There has been a significant reduction in retail genomic test costs in the past decade. The affordability of the tests will attract the consumers to give a boost to the market.

The mass affordability of sequencing has brought a paradigm shift and has led consumers to identify the risk factors and has opened the door for new applications and business models across health insurance, care delivery, and everyday life.

Know More Details About the Report

The rise in Personalized Medicine is likely to Augment Retail Genomics Sales

Growth in the personalized medicine market is set to offer an array of opportunities for players operating in the genomics market. Various pharmaceutical companies are increasingly investing in personalized medicine research. Personalized medicine enables medical practitioners to identify the exact needs of a patient and then prescribe medicines and treatments accordingly. This approach guarantees better care outcomes. Moreover, it is expected that advancements in the field of gene therapy have the potential to replace traditional drugs and surgeries by enabling doctors to treat a disorder by inserting a gene into a patient’s cell.

The use of personalized medicine therapy is on the rise as it offers cost savings, patient compliance, drug safety, early detection of diseases, and optimization of therapies. The advent of DNA and gene microarray technologies has revolutionized the field of personalized medicine, making it possible to understand the expression of all genes in the human genome in a single experiment.

Research organizations and even big pharmaceutical companies are increasing their focus on precision medicine for the development of new drugs and disease therapies and clinical testing.

US and Canada Retail Genomics Market Outlook

The US is one of the largest markets for Retail Genomics globally. The US Retail Genomics market is set to tread on the historic pattern of bust and boom during the assessment period 2021-2031.

The U.S. and Canada are expected to be the largest market share of the Retail Genomics market, owing to the factors such as increasing R&D activities, growing advanced technology, and vast commercialization of retail genomics is expected to boost the market in the countries. Also, the presence of more retail genomics companies will lead to the growth of the market in the region. An increase in government initiatives to strengthen genomics projects in Canada is expected to rise the market in the country.

Avail customized purchase options for your needs

Asia-Pacific Demand Outlook for Retail Genomics

The Asia Pacific is expected to see growth in the retail genomics market in the forecasted period owing to the entry of new players in the region. There are few strong regional players which are expected to boost the market in the given region. The increasing awareness about personalized medicine and improving lifestyle with the help of retail genomics will lead the market growth in the region.

There has been increased funding in the region for research and development which will give rise to new healthcare paradigms including genomic sequencing. Growing awareness and increasing R&D in developing countries like China and Japan about genetic sequencing and the presence of regional players in the countries will boost the market in the region. Also, there have been significant reforms taken by government bodies in the region with will accelerate the market.

Who are the Key Manufacturers and Suppliers of Retail Genomics?

Some of the leading providers of Retail Genomics include

  • 23andMe
  • Color Genomics
  • Counsyl
  • Gene by Gene
  • Laboratory Corporation of America
  • MyMedLab
  • Mapmygenome India
  • Positive Bioscience
  • Quest Diagnostics Inc.
  • Helix
  • Illumina Inc.
  • Others

Key players are focusing on new product launches is the prominent strategy of the player to increase their market share. For instance, in 2019 Helix a key player offered a test that looks for two types of cancer and cholesterol.

An Adaptive Approach to Modern-day Research Needs

Retail Genomics Market Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company

Key Segments

By Application

  • Genetic Relatedness
  • Diagnostics
  • Lifestyle, Wellness, & Nutrition
  • Reproductive Health
  • Personalized Medicine & Pharmacogenetic Testing
  • Others

By Technology

  • Sequencing
  • PCR
  • Nucleic Acid Extraction and Purification
  • Microarray
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Research Centers and Academic Institutes
  • Others

By Region

  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • BENELUX
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia
    • Thailand
    • Malaysia
    • India
    • Indonesia
  • Oceania
    • Australia
    • New Zealand
  • Middle East and Africa
    • GCC Countries
    • North Africa
    • South Africa
    • Other Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Need an Exclusive Report for your Unique Requirement?

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report on the radiation proctitis treatment industry has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.